Racial medicine: here to stay?
Open Access
- 1 March 2006
- journal article
- Published by European Molecular Biology Organization in EMBO Reports
- Vol. 7 (3) , 246-249
- https://doi.org/10.1038/sj.embor.7400654
Abstract
The success of the International HapMap Project and other initiatives may help to overcome racial profiling in medicine, but old habits die hardKeywords
This publication has 18 references indexed in Scilit:
- Are medical and nonmedical uses of large-scale genomic markers conflating genetics and 'race'?Nature Genetics, 2004
- Implications of biogeography of human populations for 'race' and medicineNature Genetics, 2004
- Will tomorrow's medicines work for everyone?Nature Genetics, 2004
- Consensus Emerges on HapMap StrategyScience, 2004
- How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.2004
- Race, Distributive Justice and the Promise of PharmacogenomicsAmerican Journal of PharmacoGenomics, 2003
- Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trialsJournal of Cardiac Failure, 1999
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986